Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients have higher IgE and IL-13 levels, suggesting immune involvement.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Targeting Interleukin-13 could help treat alopecia areata linked with atopic dermatitis.

Th22 cells are essential for Tβ15-induced hair growth in mice.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Type 2 cytokines IL-4 and IL-13 increase skin's vulnerability to Staphylococcus aureus, which could be important for treating atopic dermatitis.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Borneol Essential Oil could be a natural and safe acne treatment.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Bleach baths with 0.005% hypochlorite help manage atopic dermatitis by affecting skin cells and reducing itchiness.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Atopy and altered T cell functions contribute to Alopecia Areata.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Ferulic acid helps stabilize vitamins C and E for better skin protection from the sun, certain compounds may promote hair growth, atopic dermatitis patients have lower skin defense molecules, older men are more likely to get a type of skin cancer, and a substance called relaxin may prevent age-related skin thickening.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Dupilumab can both heal and cause hair loss.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Dupilumab may help regrow hair in people with atopic dermatitis.

Procyanidins from grape seeds reduce nerve pain by blocking specific proteins and inflammation.

Stress can slow hair growth by affecting certain cells and pathways.

Dupilumab effectively treated severe alopecia areata in a child.